Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Trial on Adenomyosis Treatment Comparing Aromatase Inhibitor Plus GnRH Analogue Versus GnRH Analog Alone

NCT03421639 is registered in ClinicalTrials.gov with Centre for Endocrinology and Reproductive Medicine, Italy as lead sponsor.

NCT NCT03421639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03421639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Trial on Adenomyosis Treatment Comparing Aromatase Inhibitor Plus GnRH Analogue Versus GnRH Analog Alone
Lead sponsor
Centre for Endocrinology and Reproductive Medicine, Italy
Phase
Phase 4
Overall status
Unknown status
Start date
December 1, 2017
Completion date
September 30, 2024
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

menstrual pain, recurrent implantation failure, uterine adenomyosis